Ticker Details
Phathom Pharmaceuticals, Inc.
IPO Date:	October 21, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$890.91M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.62 | 3.56%
Avg Daily Range (30 D):	$0.45 | 3.29%
Avg Daily Range (90 D):	$0.40 | 2.79%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	.91M
Avg Daily Volume (90 D):	.92M

Trade Size
Avg Trade Size (Sh.):	91
Avg Trade Size (Sh.) (30 D):	68
Avg Trade Size (Sh.) (90 D):	74

Institutional Trades
Total Institutional Trades:	917
Avg Institutional Trade:	$1.49M
Avg Institutional Trade (30 D):	$1.05M
Avg Institutional Trade (90 D):	$1.38M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.4M
Avg Closing Trade (30 D):	$1.22M
Avg Closing Trade (90 D):	$1.29M
Avg Closing Volume:	101.3K

News

Jan 8, 2026 @ 1:41 PM Stock Market Today: S&P 500, Dow Jones, Nasdaq 100... Source: Rishabh Mishra

Jan 8, 2026 @ 3:33 AM Phathom Pharmaceuticals Announces Pricing of $130 ... Source: Na

Oct 23, 2025 @ 12:00 PM Phathom Pharmaceuticals to Highlight VOQUEZNA® ... Source: Phathom Pharmaceuticals

Oct 20, 2025 @ 12:00 PM Phathom Pharmaceuticals to Report Third Quarter 20... Source: Phathom Pharmaceuticals

Aug 20, 2025 @ 12:00 PM Phathom Pharmaceuticals Clarifies That There Is No... Source: Nick Benedetto

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-3.76	$-.41	$-1.05
Diluted EPS	$-3.76	$-.41	$-1.05
Revenue	$147.19M	$49.5M	$39.5M
Gross Profit	$128.42M	$43.31M	$34.47M
Net Income / Loss	$-274.55M	$-29.97M	$-75.81M
Operating Income / Loss	$-213.47M	$-15.27M	$-59.92M
Cost of Revenue	$18.77M	$6.19M	$5.04M
Net Cash Flow	$-199.52M	$-14.41M	$-147.69M
PE Ratio